• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度神经胶质瘤患者中CDKN2A外显子缺失状态及新型体细胞突变

CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients.

作者信息

Sibin M K, Bhat Dhananjaya I, Lavanya Ch, Manoj M Jeru, Aakershita S, Chetan G K

机构信息

Department of Human Genetics, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.

出版信息

Tumour Biol. 2014 Feb;35(2):1467-72. doi: 10.1007/s13277-013-1201-5. Epub 2013 Sep 25.

DOI:10.1007/s13277-013-1201-5
PMID:24065197
Abstract

Over the years, deletions of CDKN2A (p16) tumor suppressor gene has been studied using FISH and multiplex PCR, with major focus on exon 2 in various cancers, and the frequency of mutation is found to be varied in different studies. In this study, we analyzed the deletion status of all three exons of p16 and frequency of exon 2 somatic point mutations in glioma from the Indian population and its clinical implications. Multiplex PCR was carried out in order to check deletion of all 3 exons in 50 glioma samples. Nonconventional PCR-SSCP analysis and sequencing was done to identify mutations in 48 cases. Deletion of at least one of the three exons of p16 INK4A was observed in ten cases (20 %). The frequencies of exon-wise deletions were 10 % for exon 1, 4 % for exon 2, and 8 % for exon 3. Two out of 48 samples were positive for mutations in p16 exon 2. One sample had a transition of G to C on position 147 with a codon change TGG to TGC which does not contribute to the protein structure. Another sample had a transversion of A to G on the position 154 with a codon change ATG to GTG with change in amino acid methionine to valine in 52nd position. Deletion pattern was found to be varied in three exons. Frequency of p16 gene mutation was less in the Indian population (4.2 %), and this mutation does not contribute to any remarkable change in protein structure.

摘要

多年来,一直使用荧光原位杂交(FISH)和多重聚合酶链反应(PCR)研究细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A,p16)肿瘤抑制基因的缺失情况,主要聚焦于各种癌症中的第2外显子,且不同研究中发现的突变频率有所不同。在本研究中,我们分析了来自印度人群的胶质瘤中p16所有三个外显子的缺失状态以及第2外显子体细胞点突变的频率及其临床意义。进行多重PCR以检测50例胶质瘤样本中所有3个外显子的缺失情况。对48例样本进行了非传统的PCR-单链构象多态性(SSCP)分析和测序以鉴定突变。在10例(20%)样本中观察到p16 INK4A的三个外显子中至少有一个缺失。外显子缺失的频率分别为:第1外显子10%,第2外显子4%,第3外显子8%。48个样本中有2个p16第2外显子突变呈阳性。一个样本在第147位发生了G到C的转换,密码子由TGG变为TGC,这对蛋白质结构无影响。另一个样本在第154位发生了A到G的颠换,密码子由ATG变为GTG,第52位氨基酸由甲硫氨酸变为缬氨酸。发现三个外显子的缺失模式各不相同。印度人群中p16基因突变频率较低(4.2%),且这种突变对蛋白质结构没有造成任何显著变化。

相似文献

1
CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients.印度神经胶质瘤患者中CDKN2A外显子缺失状态及新型体细胞突变
Tumour Biol. 2014 Feb;35(2):1467-72. doi: 10.1007/s13277-013-1201-5. Epub 2013 Sep 25.
2
Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.食管鳞状细胞癌中细胞周期调节因子的基因状态:CDKN2A(p16(INK4a) 和 p14(ARF))基因和 p53 基因是失活的主要靶点。
Carcinogenesis. 2002 Apr;23(4):645-55. doi: 10.1093/carcin/23.4.645.
3
The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors.胶质瘤细胞系和原发性肿瘤中纯合性CDKN2A/p16缺失的发生率。
Int J Oncol. 1999 Nov;15(5):975-82. doi: 10.3892/ijo.15.5.975.
4
Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.体细胞INK4a-ARF基因座突变:头颈部鳞状细胞癌基因失活的重要机制
Mol Carcinog. 2001 Jan;30(1):26-36. doi: 10.1002/1098-2744(200101)30:1<26::aid-mc1010>3.0.co;2-e.
5
Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.光化性角化病中肿瘤抑制基因p14(ARF)、p15(INK4b)、p16(INK4a)和p53的基因组不稳定性、突变及表达分析
Cancer Lett. 2008 Jun 8;264(1):145-61. doi: 10.1016/j.canlet.2008.01.042. Epub 2008 Mar 10.
6
Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.人星形细胞瘤中视网膜母细胞瘤、p53、p16(CDKN2)和p15基因的改变。
Cancer. 1996 Jul 15;78(2):287-93. doi: 10.1002/(SICI)1097-0142(19960715)78:2<287::AID-CNCR15>3.0.CO;2-S.
7
Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.野生型和恶性胶质瘤衍生的CDKN2Aβ等位基因的功能分析:一条不依赖RB的生长抑制途径的证据
Oncogene. 1997 Oct 23;15(17):2013-20. doi: 10.1038/sj.onc.1201389.
8
A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.CDKN2A基因3'非翻译区的单核苷酸多态性在散发性原发性黑色素瘤中很常见,但CDKN2B、CDKN2C、CDK4和p53基因的突变很少见。
Int J Cancer. 2001 Nov 20;95(6):388-93. doi: 10.1002/1097-0215(20011120)95:6<388::aid-ijc1069>3.0.co;2-6.
9
[Study of deletion and mutation of p16 gene in primary hepatocellular carcinoma].
Hua Xi Yi Ke Da Xue Xue Bao. 2001 Dec;32(4):492-4, 500.
10
[Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Feb;19(1):37-40.

引用本文的文献

1
CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.CDKN2A(p16)信使核糖核酸表达降低是恶性高级别胶质瘤预后不良的一个标志物。
Tumour Biol. 2015 Sep;36(10):7607-14. doi: 10.1007/s13277-015-3480-5. Epub 2015 Apr 29.
2
p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India.p16基因高甲基化:印度东北部高发地区食管癌易感性增加的生物标志物。
Tumour Biol. 2015 Mar;36(3):1627-42. doi: 10.1007/s13277-014-2762-7. Epub 2014 Nov 1.

本文引用的文献

1
CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.儿童与成人胶质母细胞瘤中 CDKN2A 缺失与 p16 免疫组化的预测价值。
Neuropathology. 2013 Aug;33(4):405-12. doi: 10.1111/neup.12014. Epub 2013 Jan 14.
2
Genetics of adult glioma.成人胶质瘤的遗传学
Cancer Genet. 2012 Dec;205(12):613-21. doi: 10.1016/j.cancergen.2012.10.009. Epub 2012 Dec 11.
3
Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.p16INK4A和p14ARF基因在口腔癌预后中的不同作用。
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):414-20. doi: 10.1158/1055-9965.EPI-07-0284.
4
PIK3CA alterations in primary (de novo) and secondary glioblastomas.原发性(新发)和继发性胶质母细胞瘤中的PIK3CA改变。
Acta Neuropathol. 2007 Mar;113(3):295-302. doi: 10.1007/s00401-006-0186-1. Epub 2007 Jan 18.
5
Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme.多形性胶质母细胞瘤患者p16基因纯合缺失分析及其与生存的相关性
J Neurosurg. 2002 May;96(5):815-22. doi: 10.3171/jns.2002.96.5.0815.
6
Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.在日本患者中,恶性胶质瘤中p16/MTS-1/CDKN2基因的纯合缺失并不常见。
Int J Oncol. 1999 Nov;15(5):983-9. doi: 10.3892/ijo.15.5.983.
7
Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer.
Int J Mol Med. 1999 Jul;4(1):61-5. doi: 10.3892/ijmm.4.1.61.
8
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.CDKN2/p16可预测少突胶质细胞瘤的生存率:与星形细胞瘤的比较。
J Neurooncol. 1999 Feb;41(3):205-11. doi: 10.1023/a:1006185220369.
9
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.ARF促进MDM2降解并使p53稳定:ARF-INK4a基因座缺失会损害Rb和p53肿瘤抑制途径。
Cell. 1998 Mar 20;92(6):725-34. doi: 10.1016/s0092-8674(00)81401-4.
10
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.Ink4a肿瘤抑制基因产物p19Arf与MDM2相互作用,并中和MDM2对p53的抑制作用。
Cell. 1998 Mar 20;92(6):713-23. doi: 10.1016/s0092-8674(00)81400-2.